单位：[1]Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Peoples R China[2]Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Peoples R China四川大学华西医院[3]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Neurol,Wuhan,Peoples R China神经内科华中科技大学同济医学院附属同济医院神经科[4]Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China
第一作者单位：[1]Cent South Univ, Xiangya Hosp, Dept Neurol, Changsha, Peoples R China
推荐引用方式(GB/T 7714)：
Yang H.,Zhou H.,Bu B.,et al.Real-world effectiveness and safety of teriflunomide in Chinese MS patients: a multi-center retrospective study[J].EUROPEAN JOURNAL OF NEUROLOGY.2022,29:644-644.
APA：
Yang, H.,Zhou, H.,Bu, B.&Quan, C..(2022).Real-world effectiveness and safety of teriflunomide in Chinese MS patients: a multi-center retrospective study.EUROPEAN JOURNAL OF NEUROLOGY,29,
MLA：
Yang, H.,et al."Real-world effectiveness and safety of teriflunomide in Chinese MS patients: a multi-center retrospective study".EUROPEAN JOURNAL OF NEUROLOGY 29.(2022):644-644
